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Breast milk has been reported to ameliorate the severity and outcome of neonatal absti-
nence syndrome (NAS). The mechanism of this beneficial effect of breast milk on NAS
remains unclear, as the negligible amount of methadone transmitted via breast milk is
unlikely to have an impact on NAS.The aim of this study was to compare the impact of dif-
ferent feeding modalities on the onset of NAS. A retrospective medical record review was
conducted on 194 methadone-maintained mother/infant dyads. Infants were categorized
on the first 2 days of life as predominantly breastfed, fed expressed human breast milk
(EBM), or formula fed. The feeding categories were then analyzed using the onset of NAS
as the outcome measure. After adjusting for confounders, there was no significant effect
of the modality of feeding on the rates of NAS requiring treatment (p=0.11). Breastfeeding
significantly delayed the onset of NAS (p=0.04).The act of breastfeeding in the first 2 days
of life had no effect on whether an infant required treatment for NAS when compared to
those fed EBM or formula.This only suggests that the advantages of breastfeeding on NAS
cannot be substantiated in a small cohort and should not discourage breastfeeding.
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INTRODUCTION
Human breast milk has been reported to ameliorate the severity
and outcome of neonatal abstinence syndrome (NAS) (1, 2). Prior
case reports and small studies have suggested that breastfeeding has
a positive effect on NAS in terms of reducing severity of neonatal
withdrawal and length of infant hospitalization (3, 4). Methadone
concentration in human breast milk was found to be low and was
considered to be unlikely to have a pharmacological effect on NAS
(5). Thus, the observed beneficial effects of human breast milk
on the severity and outcome of NAS are unlikely to be dependent
on the pharmacological dose of methadone transmitted in human
breast milk.
There is a lack of literature differentiating the effects of the
act of breastfeeding from the effects of human breast milk on the
severity and outcome of NAS. The aim of this study, therefore,
was to compare the effect of different feeding modalities on the
onset of NAS. We hypothesized that the breastfeeding process has
an independent effect on the severity and outcome of NAS among
infants of methadone-maintained mothers.
MATERIALS AND METHODS
STUDY DESIGN
We conducted a retrospective medical record review of infants
born to mothers on the methadone maintenance program
at two birthing units in Western Sydney between 2000 and
2006 inclusive. History of illicit drug use and smoking was
obtained by maternal self-reporting. Polydrug use was defined
Abbreviations: EBM, expressed human breast milk; NAS, neonatal abstinence
syndrome.
as the use of two or more different classes of addictive drugs
including methadone. In both these centers, mothers on the
methadone maintenance program are encouraged to breastfeed
their infants unless there are medical or social contraindications
(6). Ethics approval was obtained from the Institutional Ethics
Committee.
The infants were categorized based on predominant method of
feeding during the first 2 days of life. We used the first 2 days as a
cut off for our analysis to separate possible confounding factors
with regards to increased difficulties with breastfeeding when a
neonate undergoes withdrawal, which commonly occurs within
48 h after birth (7). The breastfeeding group included infants hav-
ing ≥50% of daily feeds as breast-feeds. Infants who had ingested
≥15 ml of expressed human breast milk (EBM), and who were
breastfed <3 times per day were categorized into the EBM group.
A cut off of 15 ml of EBM ingestion was based on a previous study,
which estimated this as the average amount of colostrum ingested
during the first day of life (8). Formula fed infants were defined as
those having formula for ≥50% of their feeds, and minimal EBM
ingestion (<15 ml/day).
ASSESSMENT AND TREATMENT OF NAS
Infants born to methadone-maintained mothers were observed for
signs of withdrawal using the Finnegan objective scoring system
(9). Supportive therapy was maintained from birth and phar-
macologic treatment with oral morphine for NAS was initiated
depending on the Finnegan scores.
Infants were discharged from hospital if there were no signs
of withdrawal after 5–7 days; they were feeding well and had no
adverse medical conditions or social circumstances. Infants requir-
ing pharmacotherapy for NAS were discharged 1–2 days after
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the medications were ceased. If the mother wished to discharge
her infant early, the infant had to have stable NAS scores and a
weaning dose regime was given for administration at home with
appropriate follow-up as an outpatient.
STATISTICAL ANALYSIS
Statistical analyses were performed using statistical software pack-
age, SPSS version 20.0 (SPSS Inc., Chicago, IL, USA). Meth-
ods used in this study were χ2, and analysis of variance with
post hoc comparison of means when significance was found.
Statistical significance was set at p< 0.05. The Kruskal–Wallis
test was used for non-parametric analyses where appropriate.
Multiple logistic regression analysis was used to evaluate the
correlation between the factors predictive of requirement of
treatment for NAS. Cox regression was performed with mater-
nal methadone and gestational age as covariates to estimate
the survival curve for onset of withdrawal requiring treatment
between infants categorized by feeding modality on the first 2 days
of life.
RESULTS
A total of 226 medical charts were reviewed. Infants born at
<30 weeks gestation (n= 5) and those transferred to a quaternary
hospital for surgery (n= 2) were excluded. A further 24 infants
who were nil by mouth were excluded in addition to 1 infant who
required treatment for withdrawal before the first feed. After exclu-
sion, the total sample size was 194. There were a total of 150 infants
in the formula group, 32 infants in the breast fed, group and 12 in
the EBM group.
MATERNAL CHARACTERISTICS
The maternal characteristics are summarized in Table 1. The EBM
group had a higher methadone dose compared to all other groups
(p= 0.03). There was no difference in the method of feeding if
delivered by cesarean section. Cesarean section was shown to be a
significant confounder in a previous study (10) and was therefore
included in all analyses.
INFANT CHARACTERISTICS
Table 2 outlines the infant characteristics. There were more prema-
ture infants in the EBM group and this was statistically significant
compared to the breastfed group (p= 0.02) but not the formula
fed group (p= 0.09). There was no statistically significant differ-
ence in average NAS scores (p= 0.47) or the rates of NAS requiring
pharmacologic treatment between the groups (p= 0.11), and peak
morphine dose for infants that withdrew was similar between
groups (p= 0.2).
Multiple logistic regression was performed examining variables
predictive of NAS onset requiring treatment (Table 3).
Higher maternal methadone dose (>100 mg/day) was inde-
pendently associated with an increased need for pharmacologic
treatment for NAS, whereas prematurity was associated with a
reduced risk. In addition, when controlling for maternal age, pre-
dominant breastfeeding in the first 2 days of life was associated
with a 37% reduction in need for NAS treatment. Polydrug use or
delivery by Cesarean section did not significantly impact the need
for pharmacotherapy.
Cox regression analysis was used to analyze variables predictive
of time to onset of NAS (Table 4).
Table 1 | Maternal characteristics.
Characteristics Predominantly breastfed Expressed breast milk Formula feeding p value
n=32 n=12 n=150
Maternal age, median (IQR) (years) 26.5 (22–34.3) 28 (26.3–31.5) 27 (23–30) 0.72
Smoker n (%) 5 (16) 2 (17) 41 (27) 0.30
Polydruga n (%) 12 (38) 4 (33) 37 (25) 0.30
Methadone dose, median (IQR) (mg/day) 65 (47.5–100)b 97.5 (81.3–137.5)b,c 70 (45–96.3)c 0.03
Delivery by cesarean section n (%) 7 (22) 1 (9) 41 (29) 0.49
Kruskal–Wallis test was used for non-parametric variables.
aUse of two or more different classes of addictive drugs, including methadone.
b,cMeans with the same footnote are statistically significantly different from each other.
Table 2 | Characteristics and outcome of infants.
Characteristics Predominantly breastfed Expressed breast milk Formula feeding p value
n=32 n=12 n=150
Gestational age, median (IQR) (weeks) 39 (37.5–40) 36.6 (35–39.8) 38.5 (36.7–40) 0.14
Gestation <37 weeks n (%) 4 (13)a 6 (50)a 41 (27) 0.04
Male gender, n (%) 18 (58) 8 (67) 77 (52) 0.52
Maximum dose of morphine required, median (IQR) (mg/kg/day) 0.5 (0.5–0.7) 0.7 (0.53–0.84) 0.5 (0.5–0.7) 0.20
Average NAS score, mean±SD 5.1 (1.3) 5.7 (0.9) 5.4 (1.1) 0.47
Required treatment for NAS n (%) 23 (72) 12 (100) 121 (81) 0.11
aMeans with the same footnote are statistically significantly different from each other.
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Table 3 | Multiple logistic regression model for variables predictive of
requiring pharmacologic treatment for NAS in infants of
methadone-maintained mothers.
Variables Odds ratio
(95% confidence
interval)
p value
Maternal methadone dose (mg/day) 1.03 (1.02–1.49) <0.001
Gestational age at delivery (weeks) 1.27 (1.08–1.5) 0.004
Predominantly breastfed first 2 days of life 2.12 (0.8–5.73) 0.14
Polydrug use 1.35 (0.62–3.0) 0.46
Delivery by cesarean section 1.37 (0.57–3.3) 0.48
Table 4 | Cox regression model for variables predictive of time to onset
of NAS among infants of methadone maintained mothers.
Variables Hazards ratio
(95% CI)
univariate
Hazards ratio
(95% CI)
multivariate
p value
(multivariate)
High maternal
methadone dose
(>100 mg/day)
1.65 (1.16–2.33) 1.65 (1.15–2.36) 0.007
Gestational age
<37 weeks
0.61 (0.42–0.89) 0.56 (0.38–0.83) 0.004
Predominantly
breastfed first 2 days
0.70 (0.45–1.09) 0.72 (0.45–1.15) 0.04
Delivery by cesarean
section
0.98 (0.68–1.42) 1.02 (0.70–1.49) 0.93
FIGURE 1 | Age (in hours) at which medications were commenced for
NAS within the three groups.
Breastfeeding during the first 2 days of life was associated with
a delayed onset of NAS (p= 0.04). Median time to withdrawal
for term infants was significantly lower compared to infants born
at <37 weeks (47 vs. 75 h). Figure 1 depicts the significant trend
toward the benefit of breastfeeding. The apparent benefit of for-
mula feeding over EBM after 50 h of life cannot be over interpreted
due to the small sample size of the EBM group. Similar results were
obtained on adjusted analysis.
DISCUSSION
Infants exposed to methadone in utero are at risk of developing
NAS (11). Breastfeeding is currently recommended by most health
authorities for infants born to methadone-dependent mothers
(6). Methadone-exposed mother/infant dyads are a group that
could benefit substantially from the known advantages of breast-
feeding, in particular, by promoting mother/infant bonding (12),
alleviating infant agitation (13) and decreasing maternal stress
response (14).
Jansson et al. (15) showed that the amount of methadone trans-
mitted through breast milk is in the range of 21–462 ng/mL. To
what extent this amount of methadone impacts on infants exposed
in utero remains unclear.
Our study aimed to compare the effect of the breastfeeding
process from the ingestion of human breast milk on the onset of
NAS. In particular, infants who were predominantly breastfed in
the first 2 days of life had a delayed onset of NAS compared to
infants who were fed EBM. These results are concordant with pre-
vious studies that have shown a positive effect of breastfeeding on
the outcome of NAS (4, 5). Abdel-Latif et al. (2) stated that there
was no difference between infants who were fed breast milk by
bottle or by gavage tube and those who were exclusively breastfed;
however, no statistical data or comparisons between the groups
were described.
In this study, the feeding modalities in the first 2 days were
compared, to eliminate the confounder of difficulties with breast-
feeding once an infant undergoes withdrawal, which introduces a
significant selection bias (14).
A potential weakness in this study is the small sample size of
the EBM group. It was rare to find a mother who would feed by
EBM without breastfeeding or supplementing feeds with formula.
Obtaining a clearer result of the effect of human breast milk alone
without breastfeeding would require a randomized control trial,
which would be ethically problematic.
The identification of other classes of substance misuse among
our sample population is limited by maternal self-reporting.
Routine urine toxicology was not performed on mothers who
presented for delivery, and neonatal urine toxicology was only
performed when requested. Thus, our study cannot discount the
possibility of polydrug misuse as a contributing factor to NAS
outcome as indicated by Abdel-Latif et al. (2).
It was surprising that feeding modality did not significantly
impact the likelihood of developing NAS, which is not concor-
dant with the findings of Abdel-Latif et al. (2) Our result suggests
that despite being breastfed in the first few days of life, infants
exposed to methadone in utero may have a similar chance of
developing NAS compared to formula fed infants, but would
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have a considerably delayed onset. Therefore, monitoring of the
infant for the first 5–7 days of life is critical to ensure that infants
are not sent home before they develop more severe symptoms
of NAS.
It is indeed a possibility that the more intense supportive tech-
niques (swaddling, nursing in a quiet environment, etc.) closely
associated with the act of breast feeding may help to calm and
comfort a petulant NAS infant and hence reduce the withdrawal
symptoms.
CONCLUSION
The study concludes that breastfed infants were similarly affected
by NAS as those fed by EBM or formula. We support the cur-
rent concept that breastfeeding should be encouraged for all
methadone-maintained women with infants at risk of NAS unless
medically contraindicated. The act of breastfeeding does not have
any negative impact on NAS and has additional valuable proper-
ties that should further encourage breastfeeding in this cohort of
infants.
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